Published in TB and Outbreaks Week, April 20th, 2004
Results published in the April 1, 2004, issue of the journal Nature show the vaccine triggered an immune response in the mice and dramatically reduced the level of the virus in the lungs of inoculated mice.
But researchers at the U.S. National Institute of Allergy and Infectious Diseases, which developed the gene-based vaccine, said more experiments are needed to determine if it will work in humans.
Scientists not involved...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week